Development of an Intein-Based Bioprocessing Platform for Recombinant Production of a Potent Antimicrobial Peptide: Lasioglossin-III.
The rapid emergence of antimicrobial resistance has intensified the demand for novel anti-infective agents, positioning antimicrobial peptides (AMPs) as promising therapeutic alternatives. However, large scale production of AMPs remains challenging due to their small size, cationic nature, host toxicity, and high cost...